Tag: Novo Nordisk

Novo Nordisk trims its U.S. workforce amid surging demand for diabetes and obesity drugs, reflecting broader changes in pharmaceutical manufacturing.

October 10, 2025

Novo Nordisk resubmits Awiqli for FDA review, aiming to revolutionize type 2 diabetes treatment with once-weekly insulin dosing.

October 1, 2025